How can active immunity be obtained

In a similar manner, administration of two doses of hepatitis A vaccine generates an acquired active immune response leading to long-lasting possibly lifelong protection. Immunization commonly referred to as vaccination is the deliberate induction of an immune response, and represents the single most effective manipulation of the immune system that scientists have developed. The principle behind immunization is to introduce an antigen, derived from a disease-causing organism, that stimulates the immune system to develop protective immunity against that organism, but which does not itself cause the pathogenic effects of that organism.

Learning Objectives Compare and contrast: active natural and active artifical immunity. There is then linked recognition between the activated T H 2 with high specificity for the carrier protein and this B cell. T H 2 involvement leads to co-stimulation and cytokine release resulting in IgM then IgG and generation of memory cells. The advantages of subunit vaccines are the same as toxoid vaccines with the added benefit that one can distinguish vaccinated people from infected people—for example with hepatitis B vaccination, only an adaptive immune response to the surface antigen is possible whereas with infection core and e responses occur.

Subunit vaccines share the same disadvantages as toxoid vaccines, namely the need for an adjuvant and often multiple doses , together with the frequent occurrence of local reactions at the injection site. There are several approaches to attenuating a viral pathogen for use in humans.

One involves growing the virus in a foreign host—for example, measles virus is cultivated in chick egg fibroblasts—viral replication in such circumstances results in the appearance of a number of mutant types: those mutants with enhanced virulence for the foreign host are then selected as potential vaccine strains since they generally show reduced virulence for the human host and this is a particularly useful approach for RNA viruses which have a high mutation rate.

The molecular basis of attenuation in these circumstances is not known since the process is largely empiric and it is not possible to determine which of the observed genomic nucleotide changes are associated with diminished virulence. An alternative approach is to grow the wild virus in an artificial growth medium at a temperature lower than that found in the human body—over time a strain may emerge which grows well at this lower temperature but multiplies so slowly in humans that adaptive immune responses are able to eliminate it before the virus is able to spread and cause infection—the cold-adapted live attenuated influenza vaccine is an example of this.

Live attenuated vaccines that might be used in the occupational setting include measles, mumps, rubella and chickenpox. Within the cytosol, proteolytic degradation of viral proteins occurs; the peptides produced are then loaded onto major histocompatibility complex type I molecules and the complex is displayed on the cell surface.

Circulating cytotoxic T cells Tc with the appropriate high-specificity TCRs are able to recognize the complex and release cytokines that instruct the infected cell to undergo programmed suicide apoptosis [ 12 ]. It appears that some Tc become memory cells but the basis of this is incompletely understood. Additionally, immature dendritic cells will phagocytose virus vaccine initiating the same process previously described for protein antigens that leads to the production of plasma cells, neutralizing IgG antibodies and memory B cells.

In an adequately immunized individual, when wild measles virus is inhaled, then both mechanisms of protection work—thus for virus multiplying locally at the site of infection, Tc are able to kill infected cells; for virus that evades this and spreads through the blood stream IgG antibody there will bind it and prevent disease by neutralizing attachment to the target cell [ 9 ].

One disadvantage to live attenuated vaccines is the possibility that they may cause the illness they are designed to protect against either because they revert to virulence or because for some individuals for example, those who are immunosuppressed they are insufficiently attenuated. T-independent antigens generally polysaccharides can be converted to effective T-dependent vaccines by conjugating the polysaccharide molecule to a carrier protein.

Varicella-Zoster and hepatitis B gammaglobulin IgG preparations are examples of passive immunity which have considerable applications to the occupational health situation. Google Scholar. Google Preview. Oxford University Press is a department of the University of Oxford.

It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide. Sign In or Create an Account.

Sign In. Advanced Search. Search Menu. Article Navigation. Close mobile search navigation Article Navigation. Volume Article Contents Abstract. Active and passive immunity. Vaccine types.

Conflicts of interest. Active and passive immunity, vaccine types, excipients and licensing. David Baxter David Baxter. Oxford Academic. Select Format Select format. Permissions Icon Permissions. Abstract Abstract Immunity is the state of protection against infectious disease conferred either through an immune response generated by immunization or previous infection or by other non-immunological factors. Active immunity , immunization , immunoglobulin preparations , passive immunity , vaccine excipients , vaccine licensing , vaccine types.

Google Scholar Crossref. Search ADS. Role of aluminium-containing adjuvants in antigen internalization by dendritic cells in vitro. Tak, Saunders. Janeway, Travers. SLAM CD -independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein. All rights reserved. For Permissions, please email: journals. This makes immunization a highly effective method of giving long-lasting immunity.

Artificially acquired passive immunity is protection acquired by giving a person an injection or transfusion of antibodies made by someone else. These antibodies neutralise the infectious agents in the usual way, but the protection lasts only a few weeks because the antibodies gradually break down and are not replaced. For further information, take a look at our frequently asked questions which may give you the support you need.

Have a question? If you have any concerns about anything on this site please get in contact with us here. Report a concern. Skip to main content. Explore OpenLearn. Home Get started Create a course Free courses Collections.

Search for free courses and collections.